Stock listing
Corvus Pharmaceuticals, Inc.
Selected listing: CRVS · NASDAQ · USD · US
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), Health Technology. Latest release Sep 30, 2026: Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical…

- Ticker
- NASDAQ:CRVS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (Ticker: CRVS) is a publicly traded company based in the United States, focusing on the development of innovative therapies for cancer treatment. The company is committed to addressing unmet medical needs through its unique approach to drug development.
Latest news from Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
September 30, 2026
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
September 3, 2026
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
August 27, 2026
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
August 6, 2026
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
Events
Research Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. company profile
View the public company page for Corvus Pharmaceuticals, Inc. on 6ix.
Corvus Pharmaceuticals, Inc. news
Read company news and market updates connected to Corvus Pharmaceuticals, Inc..
Corvus Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Corvus Pharmaceuticals, Inc..
Alternate listings
C17:GETTEX
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
A2AFXS:LSX
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
A2AFXS:LS
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:TRADEGATE
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
CRVS:BOATS
US · USD
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:DUS
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:FWB
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:HAM
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:MUN
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:BX
CH · CHF
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.
C17:SWB
DE · EUR
Alternate listing for Corvus Pharmaceuticals, Inc.; the primary context on this page is CRVS:NASDAQ.